We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
Cap. Flow
+$404M
Cap. Flow %
6.55%
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$197M
2
AGN
Allergan plc
AGN
+$135M
3
BHC icon
Bausch Health
BHC
+$129M
4
CVS icon
CVS Health
CVS
+$107M
5
MCK icon
McKesson
MCK
+$94.3M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$286M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$225M
3
GILD icon
Gilead Sciences
GILD
+$86.1M
4
PRGO icon
Perrigo
PRGO
+$79.4M
5
CAH icon
Cardinal Health
CAH
+$74.8M

Sector Composition

Rank Sector Weight
1 Healthcare 53.16%
2 Consumer Discretionary 5.06%
3 Energy 4.01%
4 Utilities 3.23%
5 Financials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HK
1151
DELISTED
Halcon Resources Corporation
HK
– –
-986
Closed -$656K
43 44 45 46
47

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.

  • Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
  • Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
  • Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
  • Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
  • Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
  • Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
  • Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.